Mast-Cell-Derived TNF Amplifies CD8+ Dendritic Cell Functionality and CD8+ T Cell Priming

Cell Reports

Volumn 13, Issue 2, 2015, Pages 399-411

  Dudeck, Jan ^a   Ghouse, Shanawaz Mohammed ^a   Lehmann, Christian H K ^b   Hoppe, Anja ^a   Schubert, Nadja ^a   Nedospasov, Sergei A ^c,d   Dudziak, Diana ^b   Dudeck, Anne ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^d A Leibniz Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HAPTEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENE INACTIVATION; LYMPH NODE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CULTURE; CROSS PRESENTATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-PRIMING; DENDRITIC CELLS; MAST CELLS; MICE; MICE, INBRED C57BL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84944077093     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.08.078     Document Type: Article

References (47)

1. Abraham S.N., St John A.L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 2010, 10:440-452.
2. Amaral M.M., Davio C., Ceballos A., Salamone G., Cañones C., Geffner J., Vermeulen M. Histamine improves antigen uptake and cross-presentation by dendritic cells. J. Immunol. 2007, 179:3425-3433.
3. Bedoui S., Whitney P.G., Waithman J., Eidsmo L., Wakim L., Caminschi I., Allan R.S., Wojtasiak M., Shortman K., Carbone F.R., et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 2009, 10:488-495.
4. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., Kunkel S.L., Hültner L., Röcken M. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 2000, 192:1441-1452.
5. Bryce P.J., Miller M.L., Miyajima I., Tsai M., Galli S.J., Oettgen H.C. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 2004, 20:381-392.
6. Burgdorf S., Kautz A., Böhnert V., Knolle P.A., Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007, 316:612-616.
7. Caron G., Delneste Y., Roelandts E., Duez C., Herbault N., Magistrelli G., Bonnefoy J.-Y., Pestel J., Jeannin P. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J. Immunol. 2001, 166:6000-6006.
8. Cozzi E., Ackerman K.G., Lundequist A., Drazen J.M., Boyce J.A., Beier D.R. The naive airway hyperresponsiveness of the A/J mouse is Kit-mediated. Proc. Natl. Acad. Sci. USA 2011, 108:12787-12792.
9. De Filippo K., Dudeck A., Hasenberg M., Nye E., van Rooijen N., Hartmann K., Gunzer M., Roers A., Hogg N. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 2013, 121:4930-4937.
10. de Vries V.C., Pino-Lagos K., Nowak E.C., Bennett K.A., Oliva C., Noelle R.J. Mast cells condition dendritic cells to mediate allograft tolerance. Immunity 2011, 35:550-561.
11. Du T., Friend D.S., Austen K.F., Katz H.R. Tissue-dependent differences in the asynchronous appearance of mast cells in normal mice and in congenic mast cell-deficient mice after infusion of normal bone marrow cells. Clin. Exp. Immunol. 1996, 103:316-321.
12. Dudeck A., Dudeck J., Scholten J., Petzold A., Surianarayanan S., Köhler A., Peschke K., Vöhringer D., Waskow C., Krieg T., et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011, 34:973-984.
13. Dudeck A., Suender C.A., Kostka S.L., von Stebut E., Maurer M. Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur. J. Immunol. 2011, 41:1883-1893.
14. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H.W., Park C.G., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315:107-111.
15. Edelson B.T., Kc W., Juang R., Kohyama M., Benoit L.A., Klekotka P.A., Moon C., Albring J.C., Ise W., Michael D.G., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 2010, 207:823-836.
16. Esser P.R., Wölfle U., Dürr C., von Loewenich F.D., Schempp C.M., Freudenberg M.A., Jakob T., Martin S.F. Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS ONE 2012, 7:e41340.
17. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8:478-486.
18. Gocinski B.L., Tigelaar R.E. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 1990, 144:4121-4128.
19. Gorbachev A.V., Heeger P.S., Fairchild R.L. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions. J. Immunol. 2001, 166:2323-2332.
20. Gregory G.D., Robbie-Ryan M., Secor V.H., Sabatino J.J., Brown M.A. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 2005, 35:3478-3486.
21. Grivennikov S.I., Tumanov A.V., Liepinsh D.J., Kruglov A.A., Marakusha B.I., Shakhov A.N., Murakami T., Drutskaya L.N., Förster I., Clausen B.E., et al. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 2005, 22:93-104.
22. Heib V., Becker M., Warger T., Rechtsteiner G., Tertilt C., Klein M., Bopp T., Taube C., Schild H., Schmitt E., Stassen M. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 2007, 110:946-953.
23. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., Calderon B., Schraml B.U., Unanue E.R., Diamond M.S., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322:1097-1100.
24. Honda T., Nakajima S., Egawa G., Ogasawara K., Malissen B., Miyachi Y., Kabashima K. Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity. J. Allergy Clin. Immunol. 2010, 125:1154-1156.e2.
25. Jawdat D.M., Albert E.J., Rowden G., Haidl I.D., Marshall J.S. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 2004, 173:5275-5282.
26. Jawdat D.M., Rowden G., Marshall J.S. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J. Immunol. 2006, 177:1755-1762.
27. Joulia R., Gaudenzio N., Rodrigues M., Lopez J., Blanchard N., Valitutti S., Espinosa E. Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence. Nat. Commun. 2015, 6:6174.
28. Kaplan D.H., Igyártó B.Z., Gaspari A.A. Early immune events in the induction of allergic contact dermatitis. Nat. Rev. Immunol. 2012, 12:114-124.
29. Kunder C.A., St John A.L., Li G., Leong K.W., Berwin B., Staats H.F., Abraham S.N. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J. Exp. Med. 2009, 206:2455-2467.
30. Martin S.F. Allergic contact dermatitis: xenoinflammation of the skin. Curr. Opin. Immunol. 2012, 24:720-729.
31. Martin S.F. Immunological mechanisms in allergic contact dermatitis. Curr. Opin. Allergy Clin. Immunol. 2015, 15:124-130.
32. Martin S.F., Dudda J.C., Bachtanian E., Lembo A., Liller S., Dürr C., Heimesaat M.M., Bereswill S., Fejer G., Vassileva R., et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 2008, 205:2151-2162.
33. McLachlan J.B., Hart J.P., Pizzo S.V., Shelburne C.P., Staats H.F., Gunn M.D., Abraham S.N. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 2003, 4:1199-1205.
34. Mrabet-Dahbi S., Metz M., Dudeck A., Zuberbier T., Maurer M. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp. Dermatol. 2009, 18:437-444.
35. Nigrovic P.A., Gray D.H.D., Jones T., Hallgren J., Kuo F.C., Chaletzky B., Gurish M., Mathis D., Benoist C., Lee D.M. Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am. J. Pathol. 2008, 173:1693-1701.
36. Otsuka A., Kubo M., Honda T., Egawa G., Nakajima S., Tanizaki H., Kim B., Matsuoka S., Watanabe T., Nakae S., et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS ONE 2011, 6:e25538.
37. Peschke K., Weitzmann A., Heger K., Behrendt R., Schubert N., Scholten J., Voehringer D., Hartmann K., Dudeck A., Schmidt-Supprian M., Roers A. IκB kinase 2 is essential for IgE-induced mast cell de novo cytokine production but not for degranulation. Cell Rep. 2014, 8:1300-1307.
38. Peschke K., Dudeck A., Rabenhorst A., Hartmann K., Roers A. Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation. Methods Mol. Biol. 2015, 1220:403-421.
39. Scholten J., Hartmann K., Gerbaulet A., Krieg T., Müller W., Testa G., Roers A. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res. 2008, 17:307-315.
40. Schubert N., Dudeck J., Liu P., Karutz A., Speier S., Maurer M., Tuckermann J., Dudeck A. Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed. Arthritis Rheumatol. 2015, 67:903-913.
41. Shelburne C.P., Nakano H., St John A.L., Chan C., McLachlan J.B., Gunn M.D., Staats H.F., Abraham S.N. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 2009, 6:331-342.
42. Suto H., Nakae S., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 2006, 176:4102-4112.
43. Weber F.C., Esser P.R., Müller T., Ganesan J., Pellegatti P., Simon M.M., Zeiser R., Idzko M., Jakob T., Martin S.F. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J. Exp. Med. 2010, 207:2609-2619.
44. Weber F.C., Németh T., Csepregi J.Z., Dudeck A., Roers A., Ozsvári B., Oswald E., Puskás L.G., Jakob T., Mócsai A., Martin S.F. Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J. Exp. Med. 2015, 212:15-22.
45. Wershil B.K., Wang Z.S., Gordon J.R., Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 1991, 87:446-453.
46. Wezel A., Lagraauw H.M., van der Velden D., de Jager S.C., Quax P.H., Kuiper J., Bot I. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression. Atherosclerosis 2015, 241:289-296.
47. Zhang Y., Ramos B.F., Jakschik B.A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992, 258:1957-1959.